To study the effects of inhalational and iv dexmedetomidine during intubation in awake patients
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/09/036731
- Lead Sponsor
- Department of Anaesthesiology and Intensive care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA grade I and II
Exclusion Criteria
1. KNOWN ALCOHOLIC OR DRUG ABUSERS
2.ALLERGY TO THE DRUGS INVOLVED IN THE STUDY
3. BRADYCARDIA , ANY TYPE OF ATRIOVENTRICULAR BLOCK
4. ANY CONTRAINDICATION FOR NASAL INTUBATION LIKE THROMBOCYTOPENIA AND COAGULOPATHIES
5. FULL STOMACH PATIENTS
6. RECENT UPPER RESPIRATORY TRACT INFECTIONS
7. ANTICIPATED DIFFICULT AIRWAY
8. PREGNANCY
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method COUGH SCORETimepoint: at 1 time point - during the passage of the ETT into the trachea
- Secondary Outcome Measures
Name Time Method HEMODYNAMIC PARAMETERS:( MAP, HR and spo2)Timepoint: at baseline, after infusion of study drug and every 1 min after intubation for 5 mins;PATIENT SATISFACTION SCORETimepoint: at patient follow up after 24 hours;PHARYNGO-LARYNGEAL MORBIDITTYTimepoint: AT PATIENT FOLLOW UP AFTER 24 HOURS;POST INTUBATION SCORETimepoint: AFTER PROPER PLACEMENT OF THE ETT IN THE TRACHEA;RECALL OF THE PROCEDURETimepoint: at patient follow up after 24 hours;REQUIREMENT OF ADDITIONAL BOLUSES OF 1ML OF 2% LIGNOCAINE BY SPRAY AS YOU GO TECHNIQUETimepoint: DURING AWAKE FIBEROPTIC NASOTRACHEAL INTUBATION;SEDATION SCORETimepoint: AFTER ADMINISTRATION OF THE STUDY DRUG